Laponite as carrier for controlled in vitro delivery of dexamethasone in vitreous humor models.

Eur J Pharm Biopharm

Laboratorio de Cromatografía y Espectroscopia, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), Facultad de Ciencias, Universidad de Zaragoza-CSIC, C/ Pedro Cerbuna 12, E-50009 Zaragoza, Spain.

Published: November 2016

Laponite clay is able to retain dexamethasone by simple physisorption, presumably accomplished by hydrogen bonding formation and/or complexation with sodium counterions, as shown by solid state NMR. The physisorption can be somehow modulated by changing the solvent in the adsorption process. This simple system is able to deliver dexamethasone in a controlled manner to solutions used as models for vitreous humor. The proven biocompatibility of laponite as well as its transparency in the gel state, together with the simplicity of the preparation method, makes this system suitable for future in vivo tests of ophthalmic treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejpb.2016.08.015DOI Listing

Publication Analysis

Top Keywords

vitreous humor
8
laponite carrier
4
carrier controlled
4
controlled vitro
4
vitro delivery
4
delivery dexamethasone
4
dexamethasone vitreous
4
humor models
4
models laponite
4
laponite clay
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!